| Mar'12 | Mar'11 | ||||
|---|---|---|---|---|---|
Net income | |||||
0 | 0 | ||||
Depreciation, depletion and amortization | |||||
0 | 0 | ||||
Deferred income taxes | |||||
0 | 0 | ||||
Amortization of debt issuance costs | |||||
0 | 0 | ||||
Pension and postretirement healthcare benefit (income) expense, net | |||||
0 | 0 | ||||
Stock compensation expense | |||||
0 | 0 | ||||
Other noncash items affecting net income | |||||
0 | 0 | ||||
(Increase) decrease in trade accounts receivable | |||||
0 | 0 | ||||
(Increase) decrease in related parties accounts receivable | |||||
0 | 0 | ||||
(Increase) decrease in inventories | |||||
0 | 0 | ||||
(Increase) decrease in prepaids and other assets | |||||
0 | 0 | ||||
Increase (decrease) in accounts payable and accrued liabilities | |||||
0 | 0 | ||||
Increase (decrease) in related parties accounts payable | |||||
0 | 0 | ||||
Increase (decrease) in taxes payable | |||||
0 | 0 | ||||
Other, net | |||||
0 | 0 | ||||
Cash used in operating activities | |||||
0 | 0 | ||||
Capital expenditures | |||||
0 | 0 | ||||
Proceeds from sale of assets | |||||
0 | 0 | ||||
Cash used in investing activities | |||||
0 | 0 | ||||
Reductions of debt | |||||
0 | 0 | ||||
Proceeds from borrowings | |||||
0 | 0 | ||||
Debt issuance costs and commitment fees | |||||
0 | - | ||||
Other equity, net | |||||
0 | - | ||||
Cash provided by financing activities | |||||
0 | 0 | ||||
Effects of Exchange Rate Changes on Cash and Cash Equivalents | |||||
0 | 0 | ||||
Net Increase (Decrease) in Cash and Cash Equivalents | |||||
0 | 0 | ||||